Sectors
PTCT
PTC Therapeutics, Inc.
78.01
3 x 78.18
2 x 78.40
bid
ask
-
0.49
0.62%
10:02 AM
timesize
| Ytd | 2.70% | |
| 1y | 68.16% |
77.50
day range
78.59
43.17
52 week range
90.87
| Open | 77.58 | Prev Close | 78.50 | Low | 77.50 | High | 78.59 | Mkt Cap | 6.51B |
| Vol | 32.71K | Avg Vol | 1.83M | EPS | -2.33 | P/E | -33.69 | Forward P/E | 56.82 |
| Beta | 0.53 | Short Ratio | 9.35 | Inst. Own | 117.78% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 76.76 | 200-d Avg | 72.70 | 1yr Est | 95.93 |
| Income Statement | |||
| Total Revenue | 272.55M | ||
| Revenues (USD) | 272.55M | ||
| Cost of Revenue | 28.03M | ||
| Gross Profit | 244.52M | ||
| Operating Expenses | 199.56M | ||
| Research and Development Expense | 100.87M | ||
| Selling, General and Administrative Expense | 86.18M | ||
| Operating Income | 44.96M | ||
| Interest Expense | 49.03M | ||
| Income Tax Expense | 347.00K | ||
| Net Income | -2.81M | ||
| Net Income Common Stock | -2.81M | ||
| Net Income Common Stock (USD) | -2.81M | ||
| Consolidated Income | -2.81M | ||
| Earnings per Basic Share | -0.03 | ||
| Earnings per Basic Share (USD) | -0.03 | ||
| Earnings per Diluted Share | -0.03 | ||
| Earning Before Interest & Taxes (EBIT) | 46.57M | ||
| Earning Before Interest & Taxes (USD) | 46.57M | ||
| Weighted Average Shares | 82.52M | ||
| Weighted Average Shares Diluted | 82.52M | ||
| Balance Sheet | |||
| Cash and Equivalents | 833.99M | ||
| Cash and Equivalents (USD) | 833.99M | ||
| Investments | 1.06B | ||
| Investments Current | 1.06B | ||
| Trade and Non-Trade Receivables | 219.92M | ||
| Current Assets | 2.25B | ||
| Property, Plant & Equipment Net | 129.43M | ||
| Total Assets | 2.87B | ||
| Debt Current | 305.02M | ||
| Total Debt | 395.09M | ||
| Current Liabilities | 923.60M | ||
| Debt Non-Current | 90.07M | ||
| Total Liabilities | 3.05B | ||
| Accumulated Retained Earnings (Deficit) | -2.97B | ||
| Accumulated Other Comprehensive Income | 8.47M | ||
| Shareholders Equity | -180.46M | ||
| Shareholders Equity (USD) | -180.46M | ||
| Assets Non-Current | 615.10M | ||
| Total Debt (USD) | 395.09M | ||
| Deferred Revenue | 498.00K | ||
| Goodwill and Intangible Assets | 463.03M | ||
| Inventory | 75.57M | ||
| Liabilities Non-Current | 2.13B | ||
| Trade and Non-Trade Payables | 313.05M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 17.17M | ||
| Net Cash Flow from Financing | 6.40M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -147.90M | ||
| Capital Expenditure | -1.20M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -156.00K | ||
| Issuance (Purchase) of Equity Shares | 6.40M | ||
| Net Cash Flow from Investing | -93.74M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -92.38M | ||
| Net Cash Flow from Operations | -59.04M | ||
| Effect of Exchange Rate Changes on Cash | -1.52M | ||
| Share Based Compensation | 23.42M | ||